Summary
Novo Nordisk A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Novo Nordisk A/S (Novo Nordisk or 'the company') is a pharmaceutical company that manufactures and develops biological medicines primarily focused on advancing drugs for the treatment of diabetes and other serious chronic conditions including hemophilia, human growth hormone (HGH) disorders, and obesity. The company’s portfolio includes pre-filled delivery systems for HGH, and insulin; glucagon hypokit; needles; cartridge; vials; insulin; estradiol for hormone replacement; recombinant drugs for hemophilia; glucagon; and oral antidiabetic agents. Its major products across different therapy areas include Tresiba, NovoRapid, Ryzodeg, Fiasp, Levemir, Insulatard, NovoPen, Saxenda, NordiPen, Activelle, Vagifem, and others. Novo Nordisk has operations across North America, Asia, Europe, the Middle East and Africa. The company is headquartered in Bagsvaerd, Denmark
Scope
- Detailed information on Novo Nordisk A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novo Nordisk A/S in the form of a SWOT analysis
- An in-depth view of the business model of Novo Nordisk A/S including a breakdown and examination of key business segments
- Intelligence on Novo Nordisk A/S's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novo Nordisk A/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Novo Nordisk A/S and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novo Nordisk A/S as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Novo Nordisk A/S's business structure, strategy and prospects.
'
Table of Contents
Company Snapshot
Novo Nordisk A/S: Company Overview
Novo Nordisk A/S: Overview and Key Facts
Novo Nordisk A/S: Overview
Novo Nordisk A/S: Key Facts
Novo Nordisk A/S: Key Employees
Novo Nordisk A/S: Key Employee Biographies
Novo Nordisk A/S: Major Products and Services
Novo Nordisk A/S: Company History
Novo Nordisk A/S: Management Statement
Novo Nordisk A/S: Locations and Subsidiaries
Novo Nordisk A/S: Key Competitors
Novo Nordisk A/S: Company Analysis
Novo Nordisk A/S: Business Description
Novo Nordisk A/S: SWOT Analysis
Novo Nordisk A/S: SWOT Overview
Novo Nordisk A/S: Strengths
Novo Nordisk A/S: Weaknesses
Novo Nordisk A/S: Opportunities
Novo Nordisk A/S: Threats
Novo Nordisk A/S: Corporate Financial Deals Activity
Novo Nordisk A/S: Financial Deals Overview
Novo Nordisk A/S: Targets and Partners
Novo Nordisk A/S: Top Deals 2018 - 2022YTD*
Novo Nordisk A/S: Advisors
Novo Nordisk A/S: Top Legal Advisors
Novo Nordisk A/S: Top Financial Advisors
Novo Nordisk A/S: Mergers and Acquisitions
Novo Nordisk A/S: Corporate Venturing
Novo Nordisk A/S: Capital Raising
Novo Nordisk A/S: Partnership
Novo Nordisk A/S: Recent Developments
Novo Nordisk A/S: News and Events Summary
Novo Nordisk A/S: Business Expansion
Novo Nordisk A/S: Contracts
Novo Nordisk A/S: Financial Deals
Novo Nordisk A/S: Financial Performance
Novo Nordisk A/S: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Novo Nordisk A/S: Key Facts
Table 2: Novo Nordisk A/S: Key Employees
Table 3: Novo Nordisk A/S: Company History
Table 4: Novo Nordisk A/S: Locations and Subsidiaries
Table 5: Novo Nordisk A/S: Key Competitors
Table 6: Novo Nordisk A/S: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Novo Nordisk A/S: M&A Activity by Geography (TTM*)
Table 8: Novo Nordisk A/S: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 9: Novo Nordisk A/S: M&A Average Deal Size - Value (US$m)
Table 10: Novo Nordisk A/S: Targets and Partners
Table 11: Novo Nordisk A/S: Top Deals 2018 - 2022YTD*
Table 12: Novo Nordisk A/S: Legal Advisor Ranking by Value (US$m)
Table 13: Novo Nordisk A/S: Financial Advisor Ranking by Value (US$m)
Table 14: Novo Nordisk A/S: M&A Volume and Value Trend (2018 - YTD*2022)
Table 15: Novo Nordisk A/S: M&A Activity by Geography (2018 - YTD*2022)
Table 16: Novo Nordisk A/S: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 17: Novo Nordisk A/S: Corporate Venturing by Geography (2018 - YTD*2022)
Table 18: Novo Nordisk A/S: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 19: Novo Nordisk A/S: Capital Raising by Deal Type (2018 - YTD*2022)
Table 20: Novo Nordisk A/S: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 21: Novo Nordisk A/S: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 22: Novo Nordisk A/S: News and Events Summary
Table 23: Novo Nordisk A/S: Business Expansion
Table 24: Novo Nordisk A/S: Contracts
Table 25: Novo Nordisk A/S: Financial Deals
Table 26: Novo Nordisk A/S: Financial Performance
Table 27: Novo Nordisk A/S: Strategy and Operations
List of Figures
Figure 1: Novo Nordisk A/S: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Novo Nordisk A/S: M&A Activity by Geography (TTM*)
Figure 3: Novo Nordisk A/S: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 4: Novo Nordisk A/S: M&A Average Deal Size - Value (US$m)
Figure 5: Novo Nordisk A/S: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 6: Novo Nordisk A/S: M&A Activity by Geography (2018 - YTD*2022)
Figure 7: Novo Nordisk A/S: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 8: Novo Nordisk A/S: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 9: Novo Nordisk A/S: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 10: Novo Nordisk A/S: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 11: Novo Nordisk A/S: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 12: Novo Nordisk A/S: Partnership Trend by Deal Type (2018 - YTD*2022)
